- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01271647
Classic Yin and Yang Tonic Formula for Osteopenia (CYYTO)
July 26, 2011 updated by: Shanghai University of Traditional Chinese Medicine
Randomized Controlled Trial of Classic Yin and Yang Tonic Formula in Osteopenia
The purpose of this study is to evaluate the efficacy and safety of the classic yin and yang tonic formula for osteopenia and to research the mechanism of efficacy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Osteoporosis is a growing problem worldwide, with the greatest burden resulting from fractures.
Nevertheless, the majority of fractures in adults occur in those with "osteopenia" (bone mineral density (BMD) only moderately lower than young normal individuals) Since life long drug therapy is an expensive option with uncertain consequences and side effect, natural herbal therapy offers an attractive alternative.
The classic Yin and Yang Tonic Formula (eg.Zuogui Pill, Yougui Pill) have been used for osteoporosis or osteopenia in traditional Chinese medicine(TCM) for a long time.
For this reason, Chinese guidelines for the treatment of osteopenia include natural herbal therapy, however, there is currently no randomize placebo controlled trial to verify the efficacy for treating low BMD.
This trial is randomized, double blind, placebo controlled design.
Results of this study will provide evidence regarding the value of the classic Yin and Yang tonic formula as an intervention for increase BMD and decreasing fracture risk in osteopenia.
Furthermore, the mechanisms of action can be identified by this study.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Longhua Hospital
-
Contact:
- xuejun cui, Dr.
- Phone Number: 0086-18917763017
- Email: diyicuixj@163.com
-
Contact:
- feng yang, Dr.
- Phone Number: 0086-15001721036
- Email: yangfengdudu@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMD T-scores of the hip (femoral neck or trochanter)and/or spine between -1.0 and -2.5;
- pattern differentiation is kidney deficiency in TCM.
- informed consent.
Exclusion Criteria:
- Osteoporotic (T-score< -2.5) at any site or a fracture in the past 2 years not caused by motor vehicle accident;
- prior or current use of medication that increase risks of fracture (e.g. steroids, anti-convulsants, anticoagulants,lithium);
- prior or current use of medications that modify bone metabolism (e.g. bisphosphonates, selective estrogen receptor modulators such as Raloxifene);
- use of calcium supplements above levels suggested within the recommendations of standard care (i.e., above 1200-1500 mg);
- current or prior year use of estrogen or calcitonin;
- Malignancies other than skin cancer;
- conditions that cause secondary osteoporosis (e.g. Cushing's syndrome, Marfan's syndrome);
- lactation and gestational period;
- physical or mental disabilities that will preclude informed consent or active study participation;
- supersensitivity body constitution.
- osteoporotic fracture of having operating indication.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: placebo
|
granules,18g per time,two times per day,six months
Other Names:
|
Experimental: chinese herb
|
Yin and Yang tonic granules,18g per time,two times per day,six months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
bone mineral density
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain visual analogue scales,ECOS-16 questionnaire,bone metabolism,NEI.
Time Frame: 6 months
|
pain visual analogue scales:6month ECOS-16 questionnaire:6month bone metabolism,NEI:6month
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: feng yang, doctor, Shanghai UTCM
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Anticipated)
January 1, 2012
Study Completion (Anticipated)
July 1, 2012
Study Registration Dates
First Submitted
January 3, 2011
First Submitted That Met QC Criteria
January 6, 2011
First Posted (Estimate)
January 7, 2011
Study Record Updates
Last Update Posted (Estimate)
July 28, 2011
Last Update Submitted That Met QC Criteria
July 26, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LHCTOP2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteopenia
-
Naturex SAAtlantia Food Clinical TrialsCompletedOsteopenia, GeneralizedIreland
-
National and Kapodistrian University of AthensNational Hellenic Research FoundationCompletedOsteopenia | Postmenopausal OsteopeniaGreece
-
Chinese PLA General HospitalBeijing Jishuitan Hospital; Beijing Aerospace General HospitalUnknownOsteoporosis | Osteopenia, OsteoporosisChina
-
NestléInstitut National de la Recherche Agronomique; Centre de Recherche en Nutrition...CompletedOsteoporosis, OsteopeniaFrance
-
Instituto de Investigación Hospital Universitario...Completed
-
MeddocThe Research Council of Norway; TineRecruitingOsteopenia or OsteoporosisNorway
-
Hofseth Biocare ASAMøre og Romsdal Hospital TrustActive, not recruitingOsteopenia | Osteopenia of the ElderlyNorway
-
Aarhus University HospitalCompleted
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoporosisSaudi Arabia
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoprosisSaudi Arabia
Clinical Trials on Yin and Yang tonic granules
-
Beijing Ditan HospitalCompletedHepatocellular CarcinomaChina
-
Beijing Ditan HospitalActive, not recruiting
-
Hubei Hospital of Traditional Chinese MedicineNot yet recruiting
-
Beijing Ditan HospitalXiyuan Hospital of China Academy of Chinese Medical SciencesCompletedHepatocellular CarcinomaChina
-
Children's Hospital of Fudan UniversityCompletedPrecocious PubertyChina
-
Beijing Ditan HospitalRecruitingHepatocellular CarcinomaChina
-
University of Texas Southwestern Medical CenterCompletedBipolar Disorder | Substance Use DisorderUnited States
-
Prof. Lin ZhixiuRecruiting
-
The University of Hong KongNot yet recruitingCOVID19 | Herbal MedicineHong Kong
-
Guangzhou University of Traditional Chinese MedicineCompletedPrimary Ovarian InsufficiencyChina